The continued growth of the cell and gene therapy (CGT) market will increase demand for alternative cleanroom arrangements, predicts Ravi Samavedam, chief innovation officer at Azzur Group (Hatboro, Pennsylvania). “Keeping up with market forces will require an increase in demand for therapies that will outstrip current means of production,” Samavedam said. “Building facilities requires validation…